Advisors Asset Management Inc. trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 30.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,156 shares of the company's stock after selling 12,063 shares during the quarter. Advisors Asset Management Inc.'s holdings in Cardinal Health were worth $3,741,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently added to or reduced their stakes in the company. Greykasell Wealth Strategies Inc. bought a new position in Cardinal Health during the first quarter valued at approximately $26,000. Tompkins Financial Corp raised its position in Cardinal Health by 106.7% during the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after acquiring an additional 128 shares in the last quarter. GW&K Investment Management LLC raised its position in Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock valued at $37,000 after acquiring an additional 144 shares in the last quarter. Measured Risk Portfolios Inc. bought a new position in Cardinal Health during the fourth quarter valued at approximately $47,000. Finally, NBC Securities Inc. bought a new position in Cardinal Health during the first quarter valued at approximately $48,000. Institutional investors and hedge funds own 87.17% of the company's stock.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the stock. Argus set a $189.00 price objective on shares of Cardinal Health in a research report on Friday, August 22nd. UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Evercore ISI dropped their price target on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 13th. Morgan Stanley reissued an "overweight" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Robert W. Baird lifted their price target on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research report on Wednesday, August 13th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $165.93.
View Our Latest Research Report on CAH
Cardinal Health Trading Up 0.1%
Shares of Cardinal Health stock opened at $149.48 on Friday. The company's fifty day simple moving average is $155.86 and its 200-day simple moving average is $146.83. The company has a market cap of $35.69 billion, a price-to-earnings ratio of 23.17, a PEG ratio of 1.26 and a beta of 0.73. Cardinal Health, Inc. has a 1 year low of $106.54 and a 1 year high of $168.44.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health's quarterly revenue was up .5% on a year-over-year basis. During the same quarter last year, the company posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. Cardinal Health's dividend payout ratio (DPR) is presently 31.63%.
Insiders Place Their Bets
In other news, insider Jessica L. Mayer sold 38,078 shares of the firm's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider owned 48,457 shares in the company, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the firm's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares in the company, valued at approximately $2,298,293.14. The trade was a 64.59% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock valued at $40,489,525 in the last 90 days. 0.09% of the stock is currently owned by corporate insiders.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
